Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

RNA-seq WT vs TLE3KO ( treated with AR inhibitor)

ABSTRACT: RNA-seq WT vs TLE3KO ( treated with AR inhibitor)

PROVIDER: PRJNA468819 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR7133512.fastq.gz	Fastqsanger.gz
	SRR7133513.fastq.gz	Fastqsanger.gz
	SRR7133514.fastq.gz	Fastqsanger.gz

Items per page:

1 - 3 of 3

Similar Datasets

RNA-seq WT vs TLE3KO ( treated with AR inhibitor)

Project description:Transcriptome analysis of LNCaP control and TLE3 KO cells treated with AR inhibitor

2021-05-08 | GSE114187 | GEO

RNA-seq of sipinal cord of WT, AR-24Q, AR-97Q, testosterone-treated AR-97Q mice, Scramble-ASO-treated AR-97Q mice, and Rest4-ASO #3-treated AR-97Q mice at P7

Project description:Testosterone (20 mg) was subcutaneously adminstered to AR-97Q mice at postnatal day 1 (P1). Scramble-ASO and Rest4-ASO #3 were intracerebroventriculary administred to AR-97Q mice at P1.Gene expression profiles were analysed in the spinal cord of WT, AR-24Q, AR-97Q, testosterone-treated AR-97Q mice, Scramble-ASO-treated AR-97Q mice, and Rest4-ASO #3-treated AR-97Q mice at P7.

2026-02-08 | GSE286003 | GEO

RNA-seq of sipinal cord of WT, AR-24Q, AR-97Q, testosterone-treated AR-97Q mice, Scramble-ASO-treated AR-97Q mice, and Rest4-ASO #3-treated AR-97Q mice at P7

Project description:RNA-seq of sipinal cord of WT, AR-24Q, AR-97Q, testosterone-treated AR-97Q mice, Scramble-ASO-treated AR-97Q mice, and Rest4-ASO #3-treated AR-97Q mice at P7

| PRJNA1207460 | ENA

Transcriptome profiling of castration resistant prostate cancer cells treated with novel AR N-terminal inhibitor

Project description:This study aimed at exploring how would the novel AR N-terminal inhibitor affect the androgen receptor (AR) transcriptome, especially a subset of genes that are uniquely upregulated by AR-V7 in castration resistant prostate cancer cells. We performed next-generation sequencing-based gene expression profiling (RNA-sequencing) on the castration-resistant prostate cancer celll line LNCaP-95. LNCaP-95 expresses high level of endogeneous AR-V7, and also acquired an adaptive shift towards AR-V7-mediated AR signaling activity. Beside regulating the transcription of a subset of canonical wildtype AR genes, AR-V7 also mediates a distinct transcriptional program that is independent of wildtype AR in LNCaP-95. In this experiment, LNCaP-95 cells were treated with vehicle control or the AR-N terminal inhibitor SC912. The subsequent AR transcriptomic change following compound treatment, especially the AR-V7 unique genes were assessed by RNA-seq.

2024-04-30 | GSE253122 | GEO

A. thaliana WT and ICT1 mutant treated vs. non treated with I3C

Project description:A. thaliana WT and ICT1 mutant treated vs. non treated with I3C

| PRJNA672150 | ENA

PTPN2 knockout vs WT

Project description:PTPN2 knockout vs WT

| PRJNA871237 | ENA

Rice root: Control vs auxin transport inhibitor N-1-naphthylphthalamic (NPA) treatment WT vs iaa13 mutant.

Project description:Rice root: Control vs auxin transport inhibitor N-1-naphthylphthalamic (NPA) treatment WT vs iaa13 mutant.

| PRJNA534059 | ENA